The Department of Medical Oncology and Hematology, led by Prof. Armando Santoro, is comprised of a department with sterile rooms for high-dose therapy and allergenic bone marrow transplantation, a Day Hospital section for hospitalization and specialist clinics. The team treats over 16,000 patients annually.
Activities within the Unit are directed at diagnosis and treatment of various cancerous and hematological diseases. Particular interest is directed at the development of innovative therapeutic modalities for high incidence tumors, so called “big killers”, such as breast cancer, lung cancer, and gastroenterological cancer.
There are four specialist centers available:
- The Centre for the development and application of biological therapies in oncology, which proposes the development of biological therapies. There are programs underway for experimental therapy with anti-EGF (Iressa) in lung cancers, gastrointestinal cancers and low malignancy sarcomas, as well as anti-angiogenic therapy for lung cancer, biological medicines for the treatment of prostate and kidney tumors and monoclonal antibody lymphoma for the treatment of breast cancer and lung cancer.
- The Center for diagnosis and treatment of hematological neoplasms, with particular reference to non-Hodgkin’s lymphoma and Hodgkin’s disease, acute and chronic leukemia and multiple myeloma;
- The center for high-dose therapy, which in addition to developing innovative ways for applying anti-cancerous drug dosages in myeloablative therapy with autologous stem cell support, has also started a program for allogeneic bone marrow transplantation with nonmyeloablative therapy.
- The Center for diagnosis and treatment of sarcomas and rare cancers, which manages clinical trials for neoplastic diseases such as rare soft tissue sarcomas, mesotheliomas, thymomas, medullary thyroid carcinomas and skin rashes. The center aims to evaluate the effectiveness and impact of new therapeutic strategies, chemotherapy combinations and new drugs against these diseases;
The transplants performed include adult-to-adult transplant, umbilical cord blood transplant and haploidentical stem cell transplant.
The activities of this Unit are closely related to those of other operating units at Humanitas Clinical Institute,in order to provide the patient with a multidisciplinary diagnostic-therapeutic approach that takes into account all the specific skills operating within the Institute.
The Unit of Medical Oncology and Hematology aims to ensure that the patient receive a high quality standard for diagnosis and treatment of all neoplastic diseases, all the while developing a vast range of both clinical and basic research for the possible development of innovative treatments.